Business
MANTEX: Tech breakthrough opens bioenergy market, but Q1 revenue drops and losses deepen
MANTEX: Tech breakthrough opens bioenergy market, but Q1 revenue drops and losses deepen
About this update from Mantex Ab
Q1 2025 saw a major tech breakthrough for Mantex, enabling new bioenergy market access, but revenue fell sharply and losses widened. Financing was strengthened via warrants, and commercial rollout of Biomass Analyzer 2 is planned for late 2025. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.